Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Bioscience Vaccines
company
About
Bioscience Vaccines is engaged in the development of vaccine adjuvants and companion products for infectious diseases.
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $150K
- Industries
- Biotechnology,Health Care,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Bioscience Vaccines is a life-science company with proprietary adjuvant technology referred to as Matrix Immune Modulator and is based in the Purdue Research Park in West Lafayette, Ind. The company's products originated in the laboratory of Dr. Mark Suckow of the University of Notre Dame and are based on a technology discovered at Purdue University. The company's technology has the potential to be formulated as a companion product with vaccine products already approved and marketed for use by the FDA for the prevention of specific human and animal diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$150K
Bioscience Vaccines has raised a total of
$150K
in funding over 2 rounds. Their latest funding was raised on
Jul 25, 2011 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 25, 2011 | Seed | $150K | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Bioscience Vaccines is funded by 1 investors.
Emerging Innovations Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
